rs76254681

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000163.5(GHR):​c.619-28A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.027 in 1,586,480 control chromosomes in the GnomAD database, including 831 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.042 ( 187 hom., cov: 32)
Exomes 𝑓: 0.025 ( 644 hom. )

Consequence

GHR
NM_000163.5 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.751

Publications

3 publications found
Variant links:
Genes affected
GHR (HGNC:4263): (growth hormone receptor) This gene encodes a member of the type I cytokine receptor family, which is a transmembrane receptor for growth hormone. Binding of growth hormone to the receptor leads to receptor dimerization and the activation of an intra- and intercellular signal transduction pathway leading to growth. Mutations in this gene have been associated with Laron syndrome, also known as the growth hormone insensitivity syndrome (GHIS), a disorder characterized by short stature. In humans and rabbits, but not rodents, growth hormone binding protein (GHBP) is generated by proteolytic cleavage of the extracellular ligand-binding domain from the mature growth hormone receptor protein. Multiple alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jun 2011]
GHR Gene-Disease associations (from GenCC):
  • Laron syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • short stature due to partial GHR deficiency
    Inheritance: Unknown, AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 1 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 5-42711179-A-G is Benign according to our data. Variant chr5-42711179-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255405.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.081 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GHRNM_000163.5 linkc.619-28A>G intron_variant Intron 6 of 9 ENST00000230882.9 NP_000154.1 P10912-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GHRENST00000230882.9 linkc.619-28A>G intron_variant Intron 6 of 9 1 NM_000163.5 ENSP00000230882.4 P10912-1

Frequencies

GnomAD3 genomes
AF:
0.0422
AC:
6426
AN:
152150
Hom.:
187
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0834
Gnomad AMI
AF:
0.0406
Gnomad AMR
AF:
0.0325
Gnomad ASJ
AF:
0.0397
Gnomad EAS
AF:
0.0190
Gnomad SAS
AF:
0.0246
Gnomad FIN
AF:
0.0142
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.0268
Gnomad OTH
AF:
0.0430
GnomAD2 exomes
AF:
0.0281
AC:
7050
AN:
251034
AF XY:
0.0281
show subpopulations
Gnomad AFR exome
AF:
0.0836
Gnomad AMR exome
AF:
0.0187
Gnomad ASJ exome
AF:
0.0447
Gnomad EAS exome
AF:
0.0182
Gnomad FIN exome
AF:
0.0148
Gnomad NFE exome
AF:
0.0252
Gnomad OTH exome
AF:
0.0306
GnomAD4 exome
AF:
0.0253
AC:
36328
AN:
1434212
Hom.:
644
Cov.:
27
AF XY:
0.0256
AC XY:
18304
AN XY:
715258
show subpopulations
African (AFR)
AF:
0.0862
AC:
2826
AN:
32778
American (AMR)
AF:
0.0206
AC:
920
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.0462
AC:
1198
AN:
25930
East Asian (EAS)
AF:
0.0238
AC:
941
AN:
39550
South Asian (SAS)
AF:
0.0288
AC:
2469
AN:
85680
European-Finnish (FIN)
AF:
0.0148
AC:
787
AN:
53268
Middle Eastern (MID)
AF:
0.0650
AC:
371
AN:
5710
European-Non Finnish (NFE)
AF:
0.0231
AC:
25070
AN:
1087130
Other (OTH)
AF:
0.0294
AC:
1746
AN:
59480
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
1600
3200
4800
6400
8000
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
940
1880
2820
3760
4700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0422
AC:
6433
AN:
152268
Hom.:
187
Cov.:
32
AF XY:
0.0406
AC XY:
3025
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.0833
AC:
3463
AN:
41552
American (AMR)
AF:
0.0323
AC:
494
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0397
AC:
138
AN:
3472
East Asian (EAS)
AF:
0.0191
AC:
99
AN:
5186
South Asian (SAS)
AF:
0.0246
AC:
119
AN:
4830
European-Finnish (FIN)
AF:
0.0142
AC:
151
AN:
10626
Middle Eastern (MID)
AF:
0.0612
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
0.0268
AC:
1824
AN:
68000
Other (OTH)
AF:
0.0426
AC:
90
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
318
636
954
1272
1590
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0375
Hom.:
29
Bravo
AF:
0.0447
Asia WGS
AF:
0.0200
AC:
69
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 20, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.29
DANN
Benign
0.65
PhyloP100
0.75
BranchPoint Hunter
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.20
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.20
Position offset: 28

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76254681; hg19: chr5-42711281; API